Abington, MA, United States of America

Sarah Mazzilli

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Boston University, Health Research, Inc.. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Sarah Mazzilli

Introduction

Sarah Mazzilli, based in Abington, Massachusetts, is a notable inventor with a focus on advancing medical technology. She holds one patent that addresses significant health issues related to bronchial premalignant lesions. Her work has the potential to enhance diagnostic and treatment methods in the medical field.

Latest Patents

Mazzilli's patent, titled "Methods Related to Bronchial Premalignant Lesion Severity and Progression," outlines innovative techniques for diagnosing and treating bronchial premalignant lesions. This technology utilizes specific biomarkers to determine the severity and subtype of lesions, aiding healthcare professionals in creating effective treatment plans.

Career Highlights

Throughout her career, Sarah Mazzilli has worked with prominent research institutions, including Boston University and Health Research, Inc. Her contributions in these environments have been instrumental in advancing medical research and innovation, particularly in understanding lung-related health conditions.

Collaborations

In her professional journey, Mazzilli has collaborated with esteemed colleagues such as Jennifer E Beane-Ebel and Avrum Spira. These partnerships have fostered a rich exchange of ideas and expertise, further enhancing the impact of her research and innovations in the medical field.

Conclusion

Sarah Mazzilli's work in the realm of bronchial health has marked her as a significant inventor in medical technology. With her innovative approaches and collaborations, she continues to make strides in improving diagnostic and treatment options for patients with bronchial premalignant lesions. Her contributions will likely influence the healthcare industry for years to come.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…